Free Newsletter
SPOTLIGHT: Canadians prepare OxyContin lawsuit
Free newsletter via e-mail
Tools
OxyContin class action lawsuit
A Canadian lawyer is putting the finishing touches on a class-action lawsuit that pits patients hooked on the pain drug OxyContin against its maker, Purdue Pharma. To be filed in Nova Scotia next week, the suit will claim that the company "misinformed the public and physicians" about OxyContin's suitability for long-term use. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: